Allscripts announces fourth quarter and 2018 full-year results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq end lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Allscripts (MDRX) PT Lowered to $14 at Cowen
February 22, 2019 7:12 AM ESTCowen analyst Charles Rhyee lowered the price target on Allscripts (NASDAQ: MDRX) to $14.00 (from $16.00) while maintaining a Outperform rating following the company's 4Q. Adjusted EPS of $0.20 and revenues of $538M missed consensus of $0.21 and $563M, respectively, reflecting impact of weak 3Q bookings.
MDRX introduced... More
Allscripts (MDRX) Misses Q4 EPS by 1c, FY EPS Guidance Misses
February 21, 2019 4:16 PM ESTAllscripts (NASDAQ: MDRX) reported Q4 EPS of $0.20, $0.01 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $538 million versus the consensus estimate of $563.83 million.
GUIDANCE:
Allscripts sees FY2019 EPS of $0.65-$0.70, versus the consensus of $0.81.
First quarter 2019 non-GAAP revenue... More